Market Overview
Global Coronary Stent Market size and share is currently valued at USD 12.54 billion in 2024 and is anticipated to generate an estimated revenue of USD 25.78 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.5% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
The coronary stent market encompasses a broad range of stents used in interventional cardiology, primarily for the treatment of coronary artery blockages. These include drug-eluting stents (DES), bare-metal stents (BMS), and bioabsorbable stents. Over the past decade, DES has emerged as the most widely used category due to its superior performance in preventing restenosis and reducing the need for repeat procedures. DES releases medication over time to prevent the recurrence of arterial blockages, making it the preferred choice among cardiologists and patients alike.
Technological advancements have also led to the development of next-generation stents with thinner struts, enhanced biocompatibility, and improved drug delivery mechanisms. These innovations are focused on reducing complications such as late stent thrombosis and ensuring better long-term outcomes. In addition, there has been growing interest in biodegradable or bioresorbable stents that naturally dissolve after fulfilling their function, eliminating the need for permanent implants and reducing long-term risks.
The increasing number of interventional cardiology procedures being performed globally, along with improvements in catheterization labs and healthcare infrastructure, is further fueling the growth of the market. Furthermore, favorable reimbursement policies and growing investments in cardiac care by both public and private sectors are contributing to the expansion of the coronary stent industry.
Market Segmentation
The global coronary stent market can be segmented based on product type, material, end user, and geography.
By Product Type:
- Drug-Eluting Stents (DES)
- Bare-Metal Stents (BMS)
- Bioabsorbable Stents
Drug-eluting stents dominate the market due to their ability to release anti-proliferative drugs that reduce restenosis. Bare-metal stents, once the standard in PCI, are now used selectively, mainly in patients with high bleeding risks or those who cannot tolerate long-term dual antiplatelet therapy. Bioabsorbable stents are gaining popularity for their potential to reduce long-term complications associated with permanent implants.
By Material:
- Metallic Stents
- Polymer-based Stents
Metallic stents, particularly those made of stainless steel, cobalt-chromium, and platinum-chromium, continue to lead due to their strength and compatibility. However, polymer-based stents are being explored for their biodegradability and reduced risk of late adverse events.
By End User:
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
Hospitals account for the largest share of coronary stent usage, as they offer comprehensive interventional cardiology services. Cardiac specialty centers are also prominent users due to their expertise and focus on heart-related treatments. The rise in outpatient procedures and advancements in same-day discharge protocols are increasing the relevance of ambulatory surgical centers.
Regional Analysis
Geographically, the coronary stent market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Each region exhibits distinct trends based on disease prevalence, healthcare infrastructure, and adoption of medical technologies.
North America leads the global market, driven by high incidence of cardiovascular diseases, advanced healthcare systems, and strong presence of leading medical device companies. The United States remains the dominant contributor, owing to its robust reimbursement framework and widespread adoption of cutting-edge interventional technologies.
Europe holds a significant market share due to the increasing number of aging individuals and high awareness about cardiovascular health. Countries such as Germany, France, and the United Kingdom are investing heavily in cardiovascular care and supporting the development of minimally invasive therapies.
Asia Pacific is expected to register the fastest growth during the forecast period. Rising healthcare expenditure, increasing prevalence of CAD, growing urbanization, and lifestyle changes are fueling the demand for coronary stents in the region. Additionally, improving access to healthcare services and favorable government initiatives are further supporting market growth in countries such as China, India, and Japan.
Latin America and the Middle East & Africa are emerging markets that offer untapped potential. While the adoption of coronary stents is still in a developing phase in many countries within these regions, growing medical tourism, awareness campaigns, and partnerships between local governments and international health organizations are expected to accelerate growth.
Key Companies
The coronary stent market is characterized by the presence of several leading medical device manufacturers focused on innovation, expansion, and strategic collaborations. These companies are continuously investing in research and development to introduce advanced stents that offer better efficacy, safety, and patient outcomes.
Some of the key players in the market include:
- Abbott Laboratories
- Medtronic
- Boston Scientific Corporation
- Terumo Corporation
- B. Braun Melsungen AG
- C. R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company)
- Cook Medical Inc.
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
- Biosensors International Group, Ltd.
- Stentys SA
- Lepu Medical Technology (Beijing) Co., Ltd.
- Meril Life Sciences Pvt. Ltd.
- SMT (Sahajanand Medical Technologies)
- REVA Medical, Inc.
Future Outlook
The future of the coronary stent market looks promising, with a strong focus on the development of safer, more effective, and patient-friendly stents. Continued research into minimally invasive procedures, the integration of biodegradable stent technologies, and increasing investments in interventional cardiology devices will shape the next phase of growth in this dynamic sector.
More Trending Report:
Remote Patient Monitoring Devices Market
Anti-Snoring Devices And Snoring Surgery Market
Allergy Diagnostics and Therapeutics Market
Breast Lesion Localization Methods Market
Xerostomia Therapeutics Market
Inflammatory Bowel Disease Treatment Market
Bioinformatics Services Market
Anatomic Pathology Equipment & Supplies Market
